Literature DB >> 8095851

Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.

Y Yonemura1, H Kimura, S Fushida, K Tugawa, Y Nakai, M Kaji, L Fonseca, A Yamaguchi, I Miyazaki.   

Abstract

BACKGROUND: Proliferative activities of tumors are thought to be prognostic features of malignant tumors, but their value as measured by proliferating cell nuclear antigen (PCNA) labeling remains unclear in gastric cancer.
METHODS: PCNA labeling rates (LR) were quantified in 121 paraffin-embedded biopsy specimens from primary tumors by immunocytochemistry.
RESULTS: Immunohistochemical analyses have demonstrated that PCNA presents an intense staining in the nuclei of tumor cells and mucous neck cells of gastric glands. The PCNA LR ranged from 12% to 79% (mean +/- standard deviation), and a significant correlation was found between bromodeoxyuridine labeling indices and PCNA LR: PCNA LR were closely associated with tumor size, serosal invasion, and nodal involvement. The patients with tumors with high PCNA LR (greater than 40%) were dead significantly earlier than were those with tumors with low PCNA LR: When the PCNA LR and all the clinicopathologic parameters were entered into a Cox regression model, PCNA LR emerged as an independent prognostic factor.
CONCLUSION: These results indicate that PCNA LR may be a potentially useful prognostic factor for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095851     DOI: 10.1002/1097-0142(19930415)71:8<2448::aid-cncr2820710804>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

2.  Oxidative Modification of the Potential G-Quadruplex Sequence in the PCNA Gene Promoter Can Turn on Transcription.

Authors:  Samuel C J Redstone; Aaron M Fleming; Cynthia J Burrows
Journal:  Chem Res Toxicol       Date:  2019-01-14       Impact factor: 3.739

3.  Histopathological response to preoperative chemotherapy including 5-fluorouracil additionally assessed by immunocytochemical and pharmacologic parameters in patients with advanced gastric cancer.

Authors:  H Nakano; K Namatame; T Suzuki; H Takahashi; H Sakai; T Nakamura; K Kumada
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Effect of pancreatic juice reflux into biliary tract on N-nitrosobis(2-oxopropyl)amine (BOP)-induced biliary carcinogenesis in Syrian hamsters.

Authors:  Y Ogura; S Matsuda; M Usui; N Hanamura; Y Kawarada
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Helicobacter pylori in a Korean isolate expressed proteins differentially in human gastric epithelial cells.

Authors:  Soon Ok Cho; Joo Weon Lim; Jong-Ho Jun; Kyung Hwan Kim; Hyeyoung Kim
Journal:  Dig Dis Sci       Date:  2009-08-12       Impact factor: 3.199

6.  Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.

Authors:  D C Mangham; D C Rowlands; K M Newbold; G M Reynolds; J W Fielding; M T Hallissey
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

7.  The anti-proliferative effect of proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines.

Authors:  C Sakakura; A Hagiwara; H Tsujimoto; K Ozaki; T Sakakibara; T Oyama; M Ogaki; T Takahashi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen.

Authors:  C Sakakura; A Hagiwara; H Tsujimoto; K Ozaki; T Sakakibara; T Oyama; M Ogaki; T Takahashi
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

9.  Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma.

Authors:  K Maeda; Y S Chung; S Takatsuka; Y Ogawa; N Onoda; T Sawada; Y Kato; A Nitta; Y Arimoto; Y Kondo
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

10.  Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.

Authors:  W Müller; A Schneiders; S Meier; G Hommel; H E Gabbert
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.